Technical Analysis for CATX - Perspective Therapeutics, Inc.

Grade Last Price % Change Price Change
F 6.17 -9.00% -0.61
CATX closed down 9.0 percent on Wednesday, November 20, 2024, on 1.16 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
NR7 Range Contraction -9.00%
Lower Bollinger Band Walk Weakness -9.00%

   Recent Intraday Alerts

Alert Time
Down 10% about 18 hours ago
60 Minute Opening Range Breakdown about 20 hours ago
Down 5% about 21 hours ago
Rose Above Lower Bollinger Band about 22 hours ago
Down 3% about 22 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Perspective Therapeutics, Inc. Description

Perspective Therapeutics, Inc., formerly known as Isoray, Inc., is a medical technology and radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body. The Company is the sole producer of Cesium-131 brachytherapy seeds and has a proprietary technology that utilizes the isotope lead-212 to deliver powerful alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also developing complementary imaging diagnostics that incorporate the same targeting peptides which provide the opportunity to personalize treatment and optimize patient outcomes. This “theranostic” approach enables the ability to see the specific tumor and then treat it to potentially improve efficacy and minimize toxicity associated with many other types of cancer treatments.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Biotechnology Cancer Clinical Medicine Cancer Treatment Imaging Treatment Of Cancer Medical Technology Radiation Radiation Therapy Medical Physics Personalized Medicine Brachytherapy

Is CATX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.05
52 Week Low 2.28
Average Volume 999,340
200-Day Moving Average 12.80
50-Day Moving Average 12.01
20-Day Moving Average 10.54
10-Day Moving Average 9.14
Average True Range 0.81
RSI (14) 14.53
ADX 39.49
+DI 9.19
-DI 50.79
Chandelier Exit (Long, 3 ATRs) 10.48
Chandelier Exit (Short, 3 ATRs) 8.43
Upper Bollinger Bands 14.52
Lower Bollinger Band 6.57
Percent B (%b) -0.05
BandWidth 75.41
MACD Line -1.46
MACD Signal Line -0.92
MACD Histogram -0.535
Fundamentals Value
Market Cap 3.05 Billion
Num Shares 495 Million
EPS -0.06
Price-to-Earnings (P/E) Ratio -102.83
Price-to-Sales 64.00
Price-to-Book 4.51
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.45
Resistance 3 (R3) 7.54 7.20 7.24
Resistance 2 (R2) 7.20 6.88 7.16 7.17
Resistance 1 (R1) 6.69 6.67 6.52 6.60 7.10
Pivot Point 6.35 6.35 6.26 6.30 6.35
Support 1 (S1) 5.83 6.02 5.66 5.74 5.24
Support 2 (S2) 5.49 5.82 5.45 5.17
Support 3 (S3) 4.98 5.49 5.10
Support 4 (S4) 4.89